Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMRX

Immuneering (IMRX)

Immuneering Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMRX
DateTimeSourceHeadlineSymbolCompany
20/12/202400:00GlobeNewswire Inc.Immuneering Launches Pancreatic Cancer Advisory BoardNASDAQ:IMRXImmuneering Corporation
18/12/202400:00GlobeNewswire Inc.Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025NASDAQ:IMRXImmuneering Corporation
13/12/202400:00GlobeNewswire Inc.Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced MelanomaNASDAQ:IMRXImmuneering Corporation
28/11/202400:00GlobeNewswire Inc.Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
14/11/202408:05GlobeNewswire Inc.Immuneering Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
14/11/202408:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
16/10/202404:00AllPennyStocks.comBiotech Shares Rip Following FDA Designation AnnouncementNASDAQ:IMRXImmuneering Corporation
15/10/202423:00GlobeNewswire Inc.Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic CancerNASDAQ:IMRXImmuneering Corporation
03/10/202406:11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IMRXImmuneering Corporation
18/09/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
13/09/202423:40AllPennyStocks.comBiotech Surges Premarket Following Positive Phase 2a ObservationsNASDAQ:IMRXImmuneering Corporation
13/09/202406:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
13/09/202406:05GlobeNewswire Inc.Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer PatientsNASDAQ:IMRXImmuneering Corporation
29/08/202422:00GlobeNewswire Inc.Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
07/08/202406:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMRXImmuneering Corporation
07/08/202406:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
07/08/202406:05GlobeNewswire Inc.Immuneering Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
01/08/202406:05GlobeNewswire Inc.Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic CancerNASDAQ:IMRXImmuneering Corporation
14/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
14/06/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
30/05/202406:05GlobeNewswire Inc.Immuneering to Present at the Jefferies Global Healthcare ConferenceNASDAQ:IMRXImmuneering Corporation
24/05/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
24/05/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
24/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
24/05/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMRXImmuneering Corporation
24/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
08/05/202406:05GlobeNewswire Inc.Immuneering Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMRXImmuneering Corporation
08/05/202406:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMRXImmuneering Corporation
07/05/202406:30GlobeNewswire Inc.Immuneering Recognizes Melanoma Awareness MonthNASDAQ:IMRXImmuneering Corporation
10/04/202402:00GlobeNewswire Inc.IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer ModelsNASDAQ:IMRXImmuneering Corporation
 Showing the most relevant articles for your search:NASDAQ:IMRX

Your Recent History

Delayed Upgrade Clock